REFERENCE
Neyt M, De Laet C, De Ridder A, Van Brabandt H.Cost effectiveness of drug eluting stents in Belgian practice: healthcare payer perspective. PharmacoEconomics 27: 313-327, No. 4, Jan 2009
Rights and permissions
About this article
Cite this article
DES show “unfavourable” cost effectiveness results. Pharmacoecon. Outcomes News 581, 8 (2009). https://doi.org/10.2165/00151234-200905810-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905810-00021